Status:
UNKNOWN
Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes
Lead Sponsor:
Universiti Kebangsaan Malaysia Medical Centre
Conditions:
Pancreaticoduodenectomy
Pancreatic Fistula
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
Pancreaticoduodenectomy (PD), more commonly known as Whipple's surgery is the mainstay treatment for pancreatic head and periampullary cancer. Factors contributing to PD outcomes are broadly categoriz...
Detailed Description
This is a randomized controlled trial being conducted at the Universiti Kebangsaan Malaysia Medical Center (UKMMC) with two arms; the control and treatment arms. The treatment arm will receive intrave...
Eligibility Criteria
Inclusion
- All patients undergoing pancreaticoduodenectomy that can consent to the study
Exclusion
- Patients with known allergy to human albumin
- Patients of American Society of Anaesthesiologist (ASA) physical status class 3 and above.
Key Trial Info
Start Date :
January 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 26 2022
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT04418739
Start Date
January 27 2020
End Date
November 26 2022
Last Update
June 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universiti Kebangsaan Malaysia Medical Center
Kuala Lumpur, Malaysia, 56000